Artivion | CRY - Pre Tax Profit


Artivion reported $11.4M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Integra LifeSciences USD -2.41M 6.72M Mar/2026
J&J USD 7.82B 2.86B Mar/2026
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -2.19M 20.07M Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
ResMed USD 496.15M 13.77M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Terumo JPY 31.67B 13.71B Mar/2026
Trinity Biotech USD -5.06M 10.74M Sep/2025